Phase I/II Study of Bavdegalutamide, a Proteolysis-Targeting Chimera Androgen Receptor Degrader, in Metastatic Castration-Resistant Prostate Cancer
1. 文件大小不能超过300M, 允许上传文档或压缩包等
2. 请确保上传文献的真实性、完整性,不得对原文做任何修改
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1200/jco-25-02995
文献链接: https://ascopubs.org/doi/10.1200/JCO-25-02995
其他信息:
出版社: American Society of Clinical Oncology (ASCO)
作者: Xin Gao; Benjamin Garmezy; Jacqueline Vuky; John Shen; Oliver Sartor; Cora N. Sternberg; Robert Dreicer; Maha Hussain; Arash Rezazadeh Kalebasty; Ivor J. Percent; Elisabeth I. Heath; Sunil Gandhi; Benjamin L. Maughan; Xin Zhi; Sean Landrette; Jiachang Gong; Diane Healey; Janaki Parameswaran; Daniel P. Petrylak

